Cargando…
TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2
Pulmonary fibrosis (PF) is the pathological structure of incurable fibroproliferative lung diseases that are attributed to the repeated lung injury-caused failure of lung alveolar regeneration (LAR). Here, we report that repetitive lung damage results in a progressive accumulation of the transcripti...
Autores principales: | Lv, Xiaoxi, Liu, Shanshan, Liu, Chang, Li, Yunxuan, Zhang, Tingting, Qi, Jie, Li, Ke, Hua, Fang, Cui, Bing, Zhang, Xiaowei, Liu, Yuxin, Yu, Jiaojiao, Yu, Jinmei, Li, Li, Li, Xia, Yao, Zhigang, Huang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150180/ https://www.ncbi.nlm.nih.gov/pubmed/37139431 http://dx.doi.org/10.1016/j.apsb.2023.01.008 |
Ejemplares similares
-
The cell cycle inhibitor P21 promotes the development of pulmonary fibrosis by suppressing lung alveolar regeneration
por: Lv, Xiaoxi, et al.
Publicado: (2022) -
TRIB3‒GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target
por: Liu, Shanshan, et al.
Publicado: (2021) -
TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription
por: Yu, Jin-mei, et al.
Publicado: (2019) -
TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation
por: Li, Ke, et al.
Publicado: (2020) -
TRIB3 Mediates Fibroblast Activation and Fibrosis though Interaction with ATF4 in IPF
por: Wang, Lan, et al.
Publicado: (2022)